Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART Trial Comparing Prescription and OTC Medications for Insomnia
NCT07542756Phase 4Recruiting
- Sponsor
- University of Pennsylvania
- Start
- May 2026
- Primary completion
- Jan 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin, diphenhydramine, zolpidem sublingual tablet, doxepin, trazodone hydrochloride prolonged-release tablets in Insomnia, sponsored by University of Pennsylvania. Started May 2026; status: recruiting.
02
Drugs
melatonindiphenhydraminezolpidem sublingual tabletdoxepintrazodone hydrochloride prolonged-release tablets
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07542756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07542756.